Pharmaceuticals, Biotechnology and Life Sciences
Analyst/Investor event showcases opportunities for KO-2806 (darlifarnib) in combination with PI3Kα inhibitors, KRAS inhibitors and antiangiogenic tyrosine kinase inhibitors (TKIs) Preliminary…
Fort Lauderdale, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) — PharmAGRI Capital Partners today announced its strategic focus on capturing a…
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) — UTR Therapeutics Inc., a biotechnology company advancing a novel RNA Overwriting platform,…
Aggregated presentation by day and by marketStatement of transactions in own shares from September 08th to September 12th 2025 Name of…
BERKELEY, Calif. and COPENHAGEN, Denmark, Sept. 16, 2025 (GLOBE NEWSWIRE) — Biomaterials company Marine Biologics today announced an exclusive strategic…
Launching at AMCICHAC 2025 in Partnership with BiotechlivesAMSTERDAM and MEXICO CITY, Sept. 16, 2025 (GLOBE NEWSWIRE) — 2.5 million chronic…
All 172 patients have now entered the 12-month follow-up phaseTrial involves larger surface areas, building on the approval in October…
27th Annual Conference Returns to Orange County to Connect Emerging Companies in Fields From AI to Cancer Therapies with Top…
Collaboration brings validated predictive analytics to accelerate biotech deal making and de-risk investment decisionsSAN FRANCISCO and IRVINE, Calif., Sept. 16,…
ZORYVE Allure Best of Beauty Product Image Allure Best of Beauty Breakthrough Award Winner ZORYVE (roflumilast) cream 0.15%; ZORYVE (roflumilast)…